Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

go learn the ichimoku and add the facts

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
john _a_1990_420 Member Profile
Followed By 41
Posts 3,484
Boards Moderated 0
Alias Born 02/14/14
160x600 placeholder
iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/7/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2021 4:31:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2021 7:11:29 AM
iBio Appoints William D. Clark to its Board of Directors GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics GlobeNewswire Inc. - 8/25/2021 7:30:00 AM
iBio says successful in preclinical studies for subunit COVID-19 vaccine candidate Seeking Alpha - 7/16/2021 7:24:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 6:04:34 AM
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate GlobeNewswire Inc. - 7/15/2021 5:10:00 PM
iBio establishes oncology drug discovery pipeline with three new antibody programs Seeking Alpha - 7/8/2021 4:23:04 PM
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs GlobeNewswire Inc. - 7/8/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 5:20:28 PM
iBio adds veteran biopharmaceutical executive to board of directors Seeking Alpha - 6/9/2021 4:44:08 PM
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink GlobeNewswire Inc. - 6/9/2021 4:30:00 PM
iBio to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 4:30:00 PM
iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% Seeking Alpha - 5/17/2021 10:08:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 7:16:10 AM
iBio revenue in-line Seeking Alpha - 5/17/2021 7:04:02 AM
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021 GlobeNewswire Inc. - 5/10/2021 8:15:00 AM
ChemoCentryx downgraded on narrow Adcom backing, Tilray jumps on double upgrade; in today’s analyst action Seeking Alpha - 5/7/2021 8:57:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:46:04 PM
iBio shares surge on COVID-19 study update Seeking Alpha - 5/6/2021 4:42:34 PM
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program GlobeNewswire Inc. - 5/6/2021 4:15:00 PM
Regional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers Seeking Alpha - 5/5/2021 11:00:10 AM
ATVI, TEVA, AYX and LYFT among notable premarket gainers Seeking Alpha - 5/5/2021 8:24:13 AM
john _a_1990_420   Wednesday, 11/05/14 12:25:49 PM
Re: croptop post# 10693
Post # of 26311 
go learn the ichimoku and add the facts of a possible catalyst then youll see why im still here lol this is going to be in the $2.00 range next week which is atleast %100 profit for me so no biggie ill take the gamble doing nothing lol trusting this technique which works 90% of the time

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences